Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control
Authors:
- 1 May 2020
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 38 (13) , 1371-1374
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: A Systematic ReviewClinical Gastroenterology and Hepatology, 2013
- Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical OncologyJournal of Clinical Oncology, 2013
- Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 CarriersJournal of Genetic Counseling, 2013
- A Statewide Survey of Practitioners to Assess Knowledge and Clinical Practices Regarding Hereditary Breast and Ovarian CancerGenetic Testing and Molecular Biomarkers, 2013
- Communicating BRCA1/2 genetic test results within the family: A qualitative analysisPsychology & Health, 2011
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal CancerAnnals of Internal Medicine, 2011
- Communication of BRCA Results and Family Testing in 1,103 High-Risk WomenCancer Epidemiology, Biomarkers & Prevention, 2010
- BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancerCancer, 2009
- Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relativesClinical Genetics, 2009
- Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 MutationsGenetic Testing, 2008